thrombus inhibitor (Lilly/COR)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namethrombus inhibitor (Lilly/COR)
Drug Alias NameGPIIb/IIIa inhibitors (Lilly/COR)CT-50728CT-51464CT-51688CT-51819
ClassificationSmall molecules
Mechanisms of ActionPlatelet aggregation inhibitorsIntegrin alpha-IIb/beta-3 antagonists
TargetsIntegrin alpha-IIb/beta-3
Therapy Area/IndicationsThrombosisThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCor Therapeutics IncEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsThrombosisThromboembolism

Other Information

ATC CodeN/A
Related LinksN/A